Stock market today: Stocks fall as investors rotate out of tech into Jackson Hole
Vivek Jain, Chairman and CEO of ICU Medical Inc (NASDAQ:ICUI), purchased a total of 21,929 shares of common stock on August 14, 2025, in two separate transactions, for a total value of $2,474,374. The insider buying comes as the stock trades near its 52-week low of $107, having declined nearly 14% in the past week. The price per share ranged from $112.1165 to $112.9232.
The first purchase involved 2,378 shares. The second purchase involved 19,551 shares. Following the transactions, Jain directly owns 130,149 shares and indirectly owns 88,698 shares by trust. With a market capitalization of $2.76 billion, ICU Medical maintains strong liquidity with a current ratio of 2.44. According to InvestingPro analysis, the stock appears undervalued, with 8 additional exclusive insights available to subscribers, including detailed insider trading patterns and comprehensive financial health metrics.
In other recent news, ICU Medical Inc. reported robust financial results for the second quarter of 2025, exceeding analysts’ expectations. The company posted an adjusted earnings per share (EPS) of $2.10, surpassing the projected $1.50. Revenue for the quarter reached $548.9 million, slightly higher than the anticipated $540.1 million. Additionally, ICU Medical revised its full-year guidance upwards, indicating confidence in its strategic initiatives. These developments have attracted attention from various analyst firms. While the earnings results were a highlight, the company did not announce any mergers or acquisitions. There were no reports of analyst upgrades or downgrades following the earnings announcement. Overall, these recent developments underscore ICU Medical’s positive financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.